Study Summary
This study aims to evaluate the safety and pharmacokinetic profile of SNC116 in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia
Interested in this trial?
Submit an InquiryInterventions
SNC116DRUG
Subjects will receive SNC116 injection per different dose level
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| First Hospital of Jilin University | Changchun | Jilin | China |